Answers are grounded in this paper and cite their sources.
Patients suffering from hematological malignancies (HMs) are at high risk of dying from infectious disease and specifically of coronavirus disease of 2019 (COVID 19) [1,2] or of developing chronic ...
No takes yet. Share an insight, caveat, or question.
Ré et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: